Diabetes, Obesity and Metabolism Interest Group
Diabetes is a major chronic disease of national and global epidemic proportions. It’s growth over the past few decades coincide with changes in lifestyle factors (obesity, diet, physical activity, sleep, stress) overlaid on underlying predisposing factors and pathophysiological mechanisms (genes, epigenetics, beta cell dysfunction, insulin resistance, inflammation). Complications from diabetes are legion, and affect virtually all systems of the body. Advancing our understanding the causes and complications of diabetes as well developing and implementing proven and new approaches to address these areas will require considerable collaboration across multiple disciplines (e.g., molecular genetics, physiology, biochemistry, epidemiology, clinical research, sociology & behavioral sciences, public health and policy).
To enhance cross-collaboration across the basic, translational and clinical disciplines, over 100 faculty and community members organized to form the Emory Diabetes Interest Group in 2014. The group was later renamed to the Emory Diabetes, Obesity and Metabolism Interest Group (EDOMIG) to better reflect the interconnected disciplines represented in the group. The broader Atlanta diabetes community is well represented with participants from the Emory School of Medicine, Emory School of Public Health, Emory Healthcare, the Centers for Disease Control and Prevention, Georgia Tech, and Morehouse School of Medicine. The EDOMIG is working to create a community of diabetes researchers to stimulate conversation and promote collaborations related to diabetes at Emory, enhance our strengths, and position Emory to compete for significant grants and opportunities in diabetes.
Co-led by Drs. Venkat Narayan and Roberto Pacifici, the group hosts a number of activities including an ACTSI co-sponsored Diabetes Symposium, three interdisciplinary Blue Sky Groups and a pilot grant program.
The Diabetes Blue Sky Groups are striving to stimulate research interactions and identify potential areas of collaboration in the areas of Diabetes Complications, Health Service Research, and Therapeutics by bringing together investigators with similar interests but diverse expertise who might not otherwise interact. In the first phase, six to twelve faculty members meet for informal discussion around the designated topic idea with the purpose of identifying potential areas of strengths and common interests. During later phases, these groups hold further group discussions and other activities such as monthly research presentations to help identify potential collaborative opportunities and determine concrete plans for advancing the interactions.
For more information, please contact Dr. Russ Price.
To be added to this group's email distribution listserv, please contact Onix Ramirez.